Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and ...
Prominent companies operating in the global drug discovery services market include: • Charles River Laboratories (US) • ...
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...
According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback